JPWO2022265031A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022265031A5 JPWO2022265031A5 JP2022542656A JP2022542656A JPWO2022265031A5 JP WO2022265031 A5 JPWO2022265031 A5 JP WO2022265031A5 JP 2022542656 A JP2022542656 A JP 2022542656A JP 2022542656 A JP2022542656 A JP 2022542656A JP WO2022265031 A5 JPWO2022265031 A5 JP WO2022265031A5
- Authority
- JP
- Japan
- Prior art keywords
- kidney disease
- chronic kidney
- stage
- cat
- classification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000282326 Felis catus Species 0.000 claims 19
- 208000020832 chronic kidney disease Diseases 0.000 claims 17
- 238000000034 method Methods 0.000 claims 15
- 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 6
- 210000002966 serum Anatomy 0.000 claims 5
- 238000009472 formulation Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 229940109239 creatinine Drugs 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000011301 standard therapy Methods 0.000 claims 2
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 241000282324 Felis Species 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010020850 Hyperthyroidism Diseases 0.000 claims 1
- 208000019025 Hypokalemia Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 229960002890 beraprost Drugs 0.000 claims 1
- CTPOHARTNNSRSR-APJZLKAGSA-N beraprost Chemical compound O([C@H]1C[C@@H](O)[C@@H]([C@@H]21)/C=C/[C@@H](O)C(C)CC#CC)C1=C2C=CC=C1CCCC(O)=O CTPOHARTNNSRSR-APJZLKAGSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 201000005991 hyperphosphatemia Diseases 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 208000024896 potassium deficiency disease Diseases 0.000 claims 1
- 201000001474 proteinuria Diseases 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021100475 | 2021-06-16 | ||
| JP2021100475 | 2021-06-16 | ||
| PCT/JP2022/023876 WO2022265031A1 (ja) | 2021-06-16 | 2022-06-15 | 慢性腎臓病のネコの治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022265031A1 JPWO2022265031A1 (https=) | 2022-12-22 |
| JPWO2022265031A5 true JPWO2022265031A5 (https=) | 2023-05-30 |
| JP7318818B2 JP7318818B2 (ja) | 2023-08-01 |
Family
ID=84527566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542656A Active JP7318818B2 (ja) | 2021-06-16 | 2022-06-15 | 慢性腎臓病のネコの治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12097177B2 (https=) |
| EP (1) | EP4356908B1 (https=) |
| JP (1) | JP7318818B2 (https=) |
| KR (1) | KR20240021749A (https=) |
| CN (1) | CN117396197A (https=) |
| AU (1) | AU2022294552A1 (https=) |
| BR (1) | BR112023023965A2 (https=) |
| CA (1) | CA3217697A1 (https=) |
| ES (1) | ES3054744T3 (https=) |
| MX (1) | MX2023013545A (https=) |
| WO (1) | WO2022265031A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025501556A (ja) * | 2021-12-27 | 2025-01-22 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 慢性腎臓病を診断及び治療するための組成物及び方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58124778A (ja) | 1982-01-20 | 1983-07-25 | Toray Ind Inc | ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体 |
| JPH075582B2 (ja) | 1986-01-24 | 1995-01-25 | 東レ株式会社 | ２，５，６，７−テトラノル−４，８−インタ−ｍ−フエニレンＰＧＩ▲下２▼誘導体 |
| JPH0662599B2 (ja) | 1987-10-16 | 1994-08-17 | 東レ株式会社 | ２，５，６，７―テトラノル―４，８―インタ―ｍ―フェニレンＰＧＩ２誘導体ならびにその製造法および用途 |
| CA2012081C (en) | 1989-03-14 | 2000-08-29 | Shigeki Itou | 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives |
| WO1998041210A1 (en) | 1997-03-14 | 1998-09-24 | Toray Industries, Inc. | Sustained-release prostaglandin i derivative preparation |
| ES2272914T3 (es) | 2003-05-20 | 2007-05-01 | Ethypharm | Composicion farmaceutica oral de liberacion sostenida. |
| CN101217960B (zh) | 2005-07-08 | 2010-12-15 | 东丽株式会社 | 用于改善尿毒症的治疗药和处置方法 |
| JPWO2016031949A1 (ja) | 2014-08-28 | 2017-06-22 | 東レ株式会社 | 慢性腎不全の治療薬 |
| CA3164676A1 (en) | 2019-12-23 | 2021-07-01 | Toray Industries, Inc. | Drug for preventing dialysis shift or renal death |
-
2022
- 2022-06-15 CN CN202280038404.2A patent/CN117396197A/zh active Pending
- 2022-06-15 MX MX2023013545A patent/MX2023013545A/es unknown
- 2022-06-15 US US18/565,161 patent/US12097177B2/en active Active
- 2022-06-15 CA CA3217697A patent/CA3217697A1/en active Pending
- 2022-06-15 JP JP2022542656A patent/JP7318818B2/ja active Active
- 2022-06-15 AU AU2022294552A patent/AU2022294552A1/en active Pending
- 2022-06-15 WO PCT/JP2022/023876 patent/WO2022265031A1/ja not_active Ceased
- 2022-06-15 EP EP22825019.7A patent/EP4356908B1/en active Active
- 2022-06-15 KR KR1020237035492A patent/KR20240021749A/ko active Pending
- 2022-06-15 ES ES22825019T patent/ES3054744T3/es active Active
- 2022-06-15 BR BR112023023965A patent/BR112023023965A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8536138B2 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors | |
| CA2043077C (en) | Prostaglandin analogues for use in medicine | |
| TW518222B (en) | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia | |
| EP4322942A1 (en) | Combination comprising everolimus and amcenestrant | |
| JP2001513506A (ja) | タイプｉｉ糖尿病のクロム／ビオチン治療 | |
| JPWO2022265031A5 (https=) | ||
| JPH11506732A (ja) | 白血病治療薬の製造に関するベンゾイミダゾール類の使用 | |
| CN115813920B (zh) | 1,2,4三唑并4,3-b哒嗪衍生物在制备治疗慢性肾病的药物中的应用 | |
| JP2024543345A5 (https=) | ||
| US20050043274A1 (en) | Pharmaceutical compositions and methods for lowering blood pressure and pulse rate | |
| EA004474B1 (ru) | Комбинированное лечение заболевания цнс, особенно болезни паркинсона, путём совместного введения каберголина и прамипексола | |
| PL186377B1 (pl) | Kompozycja farmaceutyczna do leczenia chorób autoimmunologicznych | |
| US6602870B2 (en) | Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same | |
| CN106474089A (zh) | 用于膀胱腔内灌注治疗的药物组合物 | |
| EP2579868B1 (en) | Oral iron deficiency therapy | |
| JP2023542932A5 (https=) | ||
| RU2023130978A (ru) | Cпособ лечения кошки с хронической болезнью почек | |
| WO2017126524A1 (ja) | 糖尿病治療剤の併用 | |
| JP2020537689A (ja) | Ａ−ノル−５αアンドロスタン化合物を含む白血球増多製剤およびその使用 | |
| JP6307710B2 (ja) | 新規使用 | |
| EP3302432A1 (en) | Treatment of acute complications of sickle cell disease | |
| CN114401724B (zh) | 一种降糖药物组合物 | |
| Ogi et al. | MO578: UBE-1099, A Novel Non-Covalent Keap1-NRF2 Inhibitor, Protects Against Renal Ischemia-Reperfusion Injury | |
| RU2261711C1 (ru) | Способ лечения гепатоза, осложненного миокардиодистрофией, у собак | |
| AU2014213552B2 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |